En poursuivant votre navigation, vous acceptez le dépôt de cookies tiers destinés à vous permettre et faciliter la navigation sur le site notamment en mémorisant vos préférences de navigation définies au cours de votre session.

3rd Nijmegen Prostate Cancer Prospects
Van der Valk Hotel Nijmegen-Lent, the Netherlands, 12 - 13 June 2020
www.radboudumc.nl/nijmegenprostatecancerprospects

The Radboud university medical center invites you to attend the 3rd Nijmegen Prostate Cancer Prospects on June 12th and 13th, 2020.

This international conference will cover state-of-the-art, novel and future aspects on prostate cancer care, from diagnostic aspects during staging, to therapeutic applications. The presentations will be arranged in sections which focus on local prostate cancer, low volume disease, local recurrent and metastatic mCRPC as well as future perspectives. An international group of experts in the field will present their work.

We would like to invite colleagues in urology, medical oncology, radiology, nuclear medicine and radiation
oncology to join us in this very exciting scientific meeting.

Prof. Dr. med. James Nagarajah and Prof. Dr. J. Fred Verzijlbergen
contact: Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.

The early bird registration until May 12, 2020 is 150 euros and includes registration, lunches and congress
dinner. After May 12 the registration fee is 175 euros. For residents the early bird rate is 100 euros and 125 euros after May 12.

For information and registration: www.radboudumc.nl/nijmegenprostatecancerprospects


Program

Friday, June 12


10:00 – 10:05 am Opening and Introduction - Prof. Dr. Fred Verzijlbergen
Staging/Diagnostics
Chairs: Prof. Dr. Jelle Barentsz and Prof. Dr. Martin Gotthardt
10:05 – 10:30 State of the art on molecular and genetic profiling - Prof. Dr. Edwin Cuppen
10:30 – 10:55 State of the art in imaging, MRI - Prof. Anwar Padhani
11:00 – 11:25 PSMA RLT - Prof. Michael Hofman (via Skype)
11:25 – 11:30 Summary - Dr. ir. Tom Scheenen
11:30 – 11:55 Break
Local PC
Chairs: Prof. Dr. Jack Schalken and Dr. Inge van Oort
11:55 – 12:20 Surgery, type, pros, cons - Prof. Dr. Steven Joniau
12:20 – 12:45 Radiotherapy for localized prostate cancer: why less is more – Dr. Piet Dirix
12:45 – 13:10 Focal therapy in prostate cancer - Prof. Dr. Jurgen Fütterer
13:10 – 13:15 Summary - Prof. Dr. Fred Witjes
13:15 – 14:00 Break
Low volume disease
Chairs: Dr. Robert Jan Smeenk and Dr. Michiel Sedelaar
14:05 – 14:30 Surgery options, pros and cons - Dr. Henk van der Poel
14:30 – 14:55 EBRT options, MDT - Dr. Robert Jan Smeenk
14:55 – 15:20 Systemic options, including RLT, tbd
15:20 – 15:45 Summary - Dr. Michiel Sedelaar
15:45 – 16:15 Break
Local recurrent and metastatic mCRPC
Chairs: Prof. Dr. Winald Gerritsen and Dr. Niven Mehra
16:15 – 16:40 Therapy options for local recurrence – Prof. Dr. Nick James
16:40 – 17:05 First/Second line therapy options, tbd
17:05 – 17:30 PSMA tandem RLT and other augmentation methods - Prof. Dr. Samer Ezziddin
17:30 – 18:00 Vision and Dosimetry, Overview currently running studies - Prof. Dr. Bernd Krause
18:00 – 18:05 Summary - Prof. Dr. Winald Gerritsen /Dr. Niven Mehra

Saturday, June 13

08:45 – 08:50 Future perspectives in PC management
Introduction and chairs: Dr. Marcel Janssen and Dr. Patrik Zámecnik
08:50 – 09:15 Radio-Ligand-Treatment, Prof. Michael Hofman
09:15 – 09:40 State of the art in imaging, pros and cons/new PET tracers - Prof. Dr. Jochen Walz
09:40 – 10:05 Molecular and Genetic Profiling. tbd
10:05 – 10:30 Future of image guidance - Dr. Fijs van Leeuwen
10:30 – 11:00 Break
11:00 – 11:25 MRI-guided radiotherapy: a game-changer for the treatment of prostate Cancer –
Dr. Linda Kerkmeijer
11:25 – 11:50 Systemic treatments - tbd
11:50 – 12:15 AI in PC management – Prof. Dr. Nassir Navab
12:15 – 12.30 Closing Remarks - Prof. James Nagarajah